These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36940916)

  • 1. SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse model.
    Alves RPDS; Wang YT; Mikulski Z; McArdle S; Shafee N; Valentine KM; Miller R; Verma SK; Batiz FAS; Maule E; Nguyen MN; Timis J; Mann C; Zandonatti M; Alarcon S; Rowe J; Kronenberg M; Weiskopf D; Sette A; Hastie K; Saphire EO; Festin S; Kim K; Shresta S
    Antiviral Res; 2023 Apr; 212():105580. PubMed ID: 36940916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
    Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
    J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential Outcomes of Infection by Wild-Type SARS-CoV-2 and the B.1.617.2 and B.1.1.529 Variants of Concern in K18-hACE2 Transgenic Mice.
    He Y; Henley J; Sell P; Comai L
    Viruses; 2023 Dec; 16(1):. PubMed ID: 38257760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Three Variants of SARS-CoV-2 In Vivo Shows Host-Dependent Pathogenicity in Hamsters, While Not in K18-hACE2 Mice.
    Toomer G; Burns W; Garcia L; Henry G; Biancofiori A; George A; Duffy C; Chu J; Sides M; Muñoz M; Garcia K; Nikolai-Yogerst A; Peng X; Westfall L; Baker R
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Pathogenesis of SARS-CoV-2 Variants of Concern in Human ACE2-Expressing Mice.
    Natekar JP; Pathak H; Stone S; Kumari P; Sharma S; Auroni TT; Arora K; Rothan HA; Kumar M
    Viruses; 2022 May; 14(6):. PubMed ID: 35746611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling SARS-CoV-2 Infection in Mice Using Lentiviral hACE2 Vectors Infers Two Modes of Immune Responses to SARS-CoV-2 Infection.
    Katzman C; Israely T; Melamed S; Politi B; Sittner A; Yahalom-Ronen Y; Weiss S; Abu Rass R; Zamostiano R; Bacharach E; Ehrlich M; Paran N; Nissim L
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo differences in neurovirulence between D614G, Delta And Omicron BA.1 SARS-CoV-2 variants.
    Bauer L; Rissmann M; Benavides FFW; Leijten L; van Run P; Begeman L; Veldhuis Kroeze EJB; Lendemeijer B; Smeenk H; de Vrij FMS; Kushner SA; Koopmans MPG; Rockx B; van Riel D
    Acta Neuropathol Commun; 2022 Sep; 10(1):124. PubMed ID: 36058935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the Pathogenicity of SARS-CoV-2 Delta and Omicron Variants by Analyzing the Expression Patterns of Immune Response Genes in K18-hACE2 Transgenic Mice.
    Kuruppuarachchi KAPP; Jang Y; Seo SH
    Front Biosci (Landmark Ed); 2022 Nov; 27(11):316. PubMed ID: 36472114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Delta SARS-CoV-2 Variant of Concern Induces Distinct Pathogenic Patterns of Respiratory Disease in K18-hACE2 Transgenic Mice Compared to the Ancestral Strain from Wuhan.
    Liu X; Mostafavi H; Ng WH; Freitas JR; King NJC; Zaid A; Taylor A; Mahalingam S
    mBio; 2022 Jun; 13(3):e0068322. PubMed ID: 35420469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
    Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
    Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
    Americo JL; Cotter CA; Earl PL; Liu R; Moss B
    Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2202069119. PubMed ID: 35679343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice humanized for MHC and hACE2 with high permissiveness to SARS-CoV-2 omicron replication.
    Le Chevalier F; Authié P; Chardenoux S; Bourgine M; Vesin B; Cussigh D; Sassier Y; Fert I; Noirat A; Nemirov K; Anna F; Bérard M; Guinet F; Hardy D; Charneau P; Lemonnier F; Langa-Vives F; Majlessi L
    Microbes Infect; 2023; 25(7):105142. PubMed ID: 37080384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a humanized mAce2 and a conditional hACE2 mouse models permissive to SARS-COV-2 infection.
    Song IW; Washington M; Leynes C; Hsu J; Rayavara K; Bae Y; Haelterman N; Chen Y; Jiang MM; Drelich A; Tat V; Lanza DG; Lorenzo I; Heaney JD; Tseng CK; Lee B; Marom R
    Mamm Genome; 2024 Jun; 35(2):113-121. PubMed ID: 38488938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
    Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
    mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential pathogenic and molecular features in neurological infection of SARS-CoV-2 Omicron BA.5.2 and BA.2.75 and Delta.
    Wang E; Yang QJ; Xu XX; Zou QC; Long Y; Ma G; Deng ZH; Zhao JB; Li MH; Zeng J
    J Med Virol; 2024 Jan; 96(1):e29357. PubMed ID: 38235532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice.
    Paull JRA; Luscombe CA; Castellarnau A; Heery GP; Bobardt MD; Gallay PA
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of Immune Evasion and Host Range Expansion by the SARS-CoV-2 B.1.1.529 (Omicron) Variant.
    Ren W; Zhang Y; Rao J; Wang Z; Lan J; Liu K; Zhang X; Hu X; Yang C; Zhong G; Zhang R; Wang X; Shan C; Ding Q
    mBio; 2023 Apr; 14(2):e0041623. PubMed ID: 37010428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    bioRxiv; 2022 Jun; ():. PubMed ID: 35734088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.